Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Research Field Drug discovery, Cell & gene therapy, Immunology

Believe in RNAi

The discovery of RNA interference (RNAi) was regarded by the scientific community as a crucial advance – evidenced by the selection of RNAi as Science journal’s 2002 “Breakthrough of the Year” and the fact that its co-discoverers, Andrew Fire and Craig Mello, were awarded the 2006 Nobel Prize in Medicine. RNAi has high specificity for targeted genes and high potency – and because of its ability to silence genes, RNAi is being investigated as a platform for the development of novel therapies by many researchers, including those in our company (co-founded by Mello).

Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Geert Cauwenbergh

Geert Cauwenbergh is the President and CEO of RXi Pharmaceuticals, USA.

Related Solutions

Research Field Drug discovery

Dental Curing Lights: Clinical Reality

| Contributed by Ocean Optics

Research Field Genetics

Measuring DNA Absorbance with the STS-UV

| Contributed by Ocean Optics

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Related Articles

Research Field Cancer

Cancer and the Microbiome

| Ivan Gladwyn-Ng, Alexander Maue

Research Field Neurological

Redirecting Cell Fate

| Jonathan James

Disease Area Cancer

Two-pronged Attack on Neuroblastoma

| Jonathan James

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register